Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.
Nguyen A, Kath JC, Hanson DC, Biggers MS, Canniff PC, Donovan CB, Mather RJ, Bruns MJ, Rauer H, Aiyar J, Lepple-Wienhues A, Gutman GA, Grissmer S, Cahalan MD, Chandy KG.
Nguyen A, et al. Among authors: chandy kg.
Mol Pharmacol. 1996 Dec;50(6):1672-9.
Mol Pharmacol. 1996.
PMID: 8967992